Literature DB >> 21355977

Nocturia as a manifestation of systemic disease.

Dev Mohan Gulur1, Amit M Mevcha1, Marcus J Drake1.   

Abstract

Nocturia is commonly referred to urologists, but the mechanisms underlying the problem, together with the appropriate clinical assessment and management, may lie outside the ordinary scope of the specialty. Some serious conditions may manifest nocturia as an early feature, often as a consequence of nocturnal polyuria (NP). Voiding frequency is influenced by rate of urine output, reservoir capacity of the bladder, lower urinary tract (LUT) sensation and psychological response. Polyuria can result from polydipsia or endocrine dysfunction. NP can result from endogenous fluid and solute shifts, cardiovascular and autonomic disease, obstructive sleep apnoea, and chronic kidney disease. Nocturia without polyuria occurs in the presence of LUT pathology, pelvic masses and sleep disturbance. Drug intake can contribute to, or counteract, each of these problems. In assessing nocturia, clinicians need to consider an undiagnosed serious condition that may manifest nocturia as an early feature, or suboptimal management of a known condition. The frequency-volume chart is a key tool in categorizing the basis of nocturia, identifying those patients with global polyuria or NP, for whom involvement of other specialties is often necessary for assessment and management. Treatment should be directed at the cause of the problem, with a view to improving long-term health and health-related quality of life. Simple steps should be undertaken by all patients, including improvement of the sleep environment and behaviour modification. Evaluation of treatment response requires objective data to corroborate subjective impressions. Some mechanisms of nocturia do not reliably improve with treatment, leading to refractory symptoms.
© 2010 THE AUTHORS. BJU INTERNATIONAL © 2010 BJU INTERNATIONAL.

Entities:  

Mesh:

Year:  2011        PMID: 21355977     DOI: 10.1111/j.1464-410X.2010.09763.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  30 in total

1.  The effect of a multidisciplinary weight loss program on renal circadian rhythm in obese adolescents.

Authors:  Kim Pauwaert; Sarah Dejonckheere; Elke Bruneel; Jolien Van Der Jeugt; Laura Keersmaekers; Saskia Roggeman; Ann De Guchtenaere; Johan Vande Walle; Karel Everaert
Journal:  Eur J Pediatr       Date:  2019-09-05       Impact factor: 3.183

Review 2.  Nocturia through the menopausal transition and beyond: a narrative review.

Authors:  Kim Pauwaert; An-Sofie Goessaert; Lynn Ghijselings; Thomas F Monaghan; Herman Depypere; Karel Everaert
Journal:  Int Urogynecol J       Date:  2021-01-13       Impact factor: 2.894

3.  Nocturia indicates a poor health status and increases mortality in male patients with type 2 diabetes mellitus.

Authors:  Hui-Ying Liu; Min-Shen Chung; Hung-Jen Wang; Rue-Tsuan Liu; Yao-Chi Chuang
Journal:  Int Urol Nephrol       Date:  2016-05-07       Impact factor: 2.370

4.  The discrepancy between European Association of Urology (EAU) guidelines and daily practice in the evaluation and management of nocturia: results of a Dutch survey.

Authors:  M S Rahnama'i; D M J Vrijens; S Hajebrahimi; G A van Koeveringe; T A T Marcelissen
Journal:  World J Urol       Date:  2019-01-17       Impact factor: 4.226

5.  The dilemma of nocturia.

Authors:  Marcus J Drake
Journal:  Can Urol Assoc J       Date:  2012-10       Impact factor: 1.862

6.  Nocturia: focus on etiology and consequences.

Authors:  Jeffrey P Weiss
Journal:  Rev Urol       Date:  2012

Review 7.  Desmopressin in the treatment of nocturia: clinical evidence and experience.

Authors:  Fara M Friedman; Jeffrey P Weiss
Journal:  Ther Adv Urol       Date:  2013-12

Review 8.  Nocturia: aetiology and treatment in adults.

Authors:  Hasan Dani; Ashanda Esdaille; Jeffrey P Weiss
Journal:  Nat Rev Urol       Date:  2016-07-26       Impact factor: 14.432

9.  The evaluation and management of persistent nocturia.

Authors:  Dima Raskolnikov; Fara M Friedman; Dhanan J Etwaru; Jeffrey P Weiss
Journal:  Curr Urol Rep       Date:  2014-09       Impact factor: 3.092

Review 10.  Nocturia: Current Evaluation and Treatment for Urology.

Authors:  Tony Nimeh; Pedro Alvarez; Naem Mufarreh; Lori B Lerner
Journal:  Curr Urol Rep       Date:  2015-09       Impact factor: 3.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.